ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Mouse Models, Lupus"

  • Abstract Number: 1665 • ACR Convergence 2022

    The TLR7/8 Inhibitor Enpatoran Reverses Established Kidney Disease in the Interferon-Alpha-Accelerated NZB/W Mouse Model of Lupus

    Julia Bruttger1, Andrew Bender2, Sonja Reissig1, Amy Kao3 and Philipp Haselmayer1, 1the healthcare business of Merck KGaA, Darmstadt, Germany, 2TIP Immunology, EMD Serono, Billerica, MA, 3EMD Serono, Billerica, MA

    Background/Purpose: Activation of toll-like receptor 7 and 8 (TLR7/8) signaling by single-stranded RNA results in immune cell stimulation and inflammatory cytokine production, a normal circumstance…
  • Abstract Number: 1666 • ACR Convergence 2022

    Differentiation of Injury-associated Macrophages in Lupus Kidneys Is Conserved in Humans and Lupus Mouse Models

    Paul Hoover1, David Lieb2, Stephen Li2, Chirag Raparia3, Accelerating Medicines Partnership SLE/RA4, Arnon Arazi5, Nir Hacohen2 and Anne Davidson6, 1Brigham and Women's Hospital, Boston, MA, 2Broad Institute, Cambridge, MA, 3Donald and Barbara Zucker School of Medicine At Hofstra/Northwell, Shoreham, NY, 4NIH, Bethesda, MD, 5Feinstein Institutes for Medical Research, Melrose, MA, 6Feinstein Institutes for Medical Research, Manhasset, NY

    Background/Purpose: Infiltrating monocytes acquire functions that support kidney remodeling in response to tissue damage in lupus nephritis. This process of monocyte differentiation has been difficult…
  • Abstract Number: 1698 • ACR Convergence 2022

    LINE1 Reverse Transcriptase Inhibitors Abrogate Type 1 Interferon Responses

    Daniel Rios1, Nafeeza Hafeez1, Brian Desrosiers1, Shradha Rao1, Jess Floro1, Joelle Baddour1, Nisha Perez2, Greg Bisacchi2, Oliver Saunders2, Donna Romero1, Menachem Fromer2, Enrique Garcia-Rivera2, Wilson McKerrow2, Julie Behr2, Bryan Thornlow2, Dennis Zaller2, David Proia2 and Wenyan Miao2, 1Rome Therapeutics, Cambridge, MA, 2Rome Tx, Cambridge, MA

    Background/Purpose: Transposable elements (TEs) are mobile DNA elements that can replicate and move from one position to another within the host genome. Through co-evolution, TEs…
  • Abstract Number: 1707 • ACR Convergence 2022

    Exploring the Role of Lipocalin-2 in Neuropsychiatric SLE

    Chaim Putterman1, Sayra Garcia-Murillo2 and Elise Mike3, 1Albert Einstein College of Medicine, Bronx, NY, 2Albert Einstein College of Medicine, New York, NY, 3John Hopkins University, Baltimore, MD

    Background/Purpose: While the etiology of neuropsychiatric lupus (NPSLE) is not fully understood, blood brain barrier (BBB) disruption and localized neuroinflammation are potential mechanisms that contribute…
  • Abstract Number: 0472 • ACR Convergence 2021

    An Atlas of Human and Mouse Intrarenal Immune Cells in Lupus Nephritis Reveals Homologous Immune Populations Across Common Mouse Strains and Species

    Paul Hoover1, Michael Peters2, David Lieb2, Runci Wang3, Garett Dunlap4, Deepak Rao1, Nir Hacohen2 and Anne Davidson5, 1Brigham and Women's Hospital, Boston, MA, 2Broad Institute, Cambridge, MA, 3Brigham and Women’s Hospital, Boston, MA, 4Harvard University, Somerville, MA, 5Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, NY

    Background/Purpose: We discovered 21 immune cell-types in lupus nephritis kidney biopsies as part of the Accelerating Medicines Partnership (AMP) consortium. These immune cells are the…
  • Abstract Number: 0534 • ACR Convergence 2021

    Lymphatic Dysfunction in Murine Lupus Photosensitivity

    William Ambler1, Noa Schwartz2, Jin Yeon Shin3, Rahgu Kataru4, Camila Carballo5, Scott Rodeo6, Babak Mehrara4 and Theresa Lu7, 1Division of Pediatric Rheumatology, Department of Rheumatology, Hospital for Special Surgery. HSS Research Institute, Hospital for Special Surgery, New York, NY, 2Department of Medicine, Division of Rheumatology, Albert Einstein College of Medicine, New York, NY, 3Department of Surgery, Division of Plastic and Reconstructive Surgery Memorial Sloan Kettering, New York, NY, 4Department of Surgery, Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering, New York, NY, 5HSS Research Institute, Hospital for Special Surgery, New York, NY, 6HSS Research Institute, Hospital for Special Surgery; Department of Orthopedics, Hospital for Special Surgery, New York, NY, 7Hospital for Special Surgery, New York, NY

    Background/Purpose: The lymphatic system is composed of vessels which carry fluid, soluble molecules, and cells from peripheral tissue to draining lymph nodes. Photosensitivity, an exaggerated…
  • Abstract Number: 0537 • ACR Convergence 2021

    The Clinical, Oral Small Molecule IRAK4 Inhibitor, GS-5718, Improves Survival and Reduces Disease Pathologies by Modulating Multiple Inflammatory Endpoints in the Murine NZB/W Model of Spontaneous Lupus

    Adam Yadon1, Vanessa Gorney2, Angie Hammond3, Ethan Grant2 and Astrid Clarke3, 1Gilead Sciences, Inc., Seattle, WA, 2Gilead Sciences, Inc, Foster City, CA, 3Gilead Sciences, Inc, Seattle, WA

    Background/Purpose: Lupus is a heterogenous autoimmune disease characterized by loss of immune tolerance, production of nucleic acid:autoantibody immune complexes, immune cell hyperactivation, and increased proinflammatory…
  • Abstract Number: 0538 • ACR Convergence 2021

    Strengthening Nuclear Envelope Ameliorates UVB-triggered Skin Inflammation and Kidney Damage in Lupus Mice

    Xing Lyu1, Minghui Li2, Ping L Zhang3, Victoria Werth4 and Ming-Lin Liu4, 1Tianjin Medical University General Hospital, Philadelphia, PA, 2Tianjin Medical University General Hospital, Tianjin, China (People's Republic), 3Division of Anatomic Pathology,Beaumont Laboratories, Beaumont Health, Royal Oak, MI, 4University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Ultraviolet B (UVB) exposure triggers lupus flare by worsening skin lesions and systemic symptoms such as lupus nephritis. The effects of UVB-induced skin inflammation…
  • Abstract Number: 0539 • ACR Convergence 2021

    Vgll3-transgenic Autoimmune Mice Display Features of Cutaneous Fibrosis

    Mehrnaz Gharaee-Kermani1, Allison Billi2, Marisa Hildebrandt2, Jacob Martens3, Rachael Wasikowski2, Joanne (Michelle) Kahlenberg1 and Johann Gudjonsson2, 1Internal Medicine - Division of Rheumatology and Department of Dermatology, University of Michigan, Ann Arbor, MI, 2Department of Dermatology, University of Michigan, Ann Arbor, MI, 3Graduate Program in Immunology, University of Michigan, Ann Arbor, MI, USA, Ann Arbor, MI

    Background/Purpose: Fibrosis is characterized by collagen deposition, fibro/myofibroblast accumulation, and extracellular matrix remodeling and can lead to disfiguring skin changes. In cutaneous lupus, scar formation…
  • Abstract Number: 0540 • ACR Convergence 2021

    Behavioral Deficits May Precede Influx of Brain-Infiltrating Macrophages in Neuropsychiatric Symptoms of Systemic Lupus Erythematosus

    Hadijat Makinde, Miranda Gurra, Yidan Wang, Sara Radecki and Carla Cuda, Northwestern University, Chicago, IL

    Background/Purpose: Systemic lupus erythematosus (SLE) is a complex autoimmune disease that affects many end organs including the brain. Despite a prevalence of over 50% in…
  • Abstract Number: 1487 • ACR Convergence 2021

    Type I Interferon Modulates Langerhans Cell ADAM17 in Lupus to Contribute to Photosensitivity

    Thomas Li1, Keila Veiga2, Noa Schwartz3, Jose Lora4, Yong Liu4, Ali Jabbari5, William Shipman1, Mehdi Rashighi6, James Krueger7, Niroshana Anandasabapathy4, David Oliver8, Yurii Chinenov8, Carl Blobel1 and Theresa Lu1, 1Hospital for Special Surgery, New York, NY, 2New York Medical College, Hawthorne, NY, 3Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, 4Weill Cornell Medicine, New York, NY, 5University of Iowa, Iowa City, IA, 6University of Massachusetts Medical School, Worcester, MA, 7Rockefeller University, New York, NY, 8David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

    Background/Purpose: Photosensitivity is a common feature in the autoimmune disease lupus erythematosus (LE) where patients develop inflammatory skin lesions in response to ultraviolet radiation (UVR).…
  • Abstract Number: 1500 • ACR Convergence 2021

    Expression of Neuropilin-1 Is Significantly Increased in Dendritic Cells and CD4 + T Cells and It Correlates Disease Activity in the Patients with Systemic Lupus Erythematosus

    Yunjung Choi1, Eun-gyeong Lee1, Yu-Mi Lee2, Myeung-Su Lee3, Chang-Hoon Lee3, Chong Hyuk Chung3 and Wan-Hee yoo1, 1Research Institute of Clinical Medicine of Jeonbuk national university-Biomedical Research Institute of Jeonbuk national university hospital, Jeonju, Republic of Korea, 2Jeonbuk National University Hospital, Jeonju, Republic of Korea, 3Wonkwang University Hospital, Iksan, Republic of Korea

    Background/Purpose: Neuropilin-1 (NRP-1) is a transmembrane glycoprotein that acts as a receptor of class III/IV semaphorins which role in the pathogenesis of autoimmune diseases. The…
  • Abstract Number: 1906 • ACR Convergence 2021

    IL-13Ra1-Mediated Signaling Regulates Age-Associated/Autoimmune B-Cell Expansion and Lupus Pathogenesis

    Danny Flores Castro1, Zhu Chen2, Sanjay Gupta3, Michela Manni3, Juan Rivera Correa3, Max Chao4, Yurii Chinenov4, Tania Pannellini5, Habib Zaghouni6, Rolf Jessberger7 and Alessandra Pernis8, 1Autoimmunity and Inflammation Program, Hospital for Special Surgery, Palisades Park, NJ, 2Department of Rheumatology and Immunology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China (People's Republic), 3Autoimmunity and Inflammation Program, Hospital for Special Surgery, New York, NY, 4David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 5Research Division and Precision Medicine Laboratory, Hospital for Special Surgery, New York, NY, 6Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, MO, 7Institute of Physiological Chemistry, Technische Universitat, Dresden, Germany, 8Department of Medicine, Weill Cornell Medicine, New York, NY

    Background/Purpose: Age-associated B cells (ABCs) are an emerging B cell subset that aberrantly expand in SLE. ABC generation and differentiation exhibit marked sexual dimorphism and…
  • Abstract Number: 0006 • ACR Convergence 2021

    Metabolic Characteristics of Age-related B Cells in Lupus-prone Mice and Effects on Follicular Helper T Cells

    Ivan Ramirez1, Betty Diamond2 and Sun Jung Kim3, 1Northwell, Little Neck, NY, 2Northwell Health, Manhasset, NY, 3Feinstein Institutes for Medical Research, Manhasset, NY

    Background/Purpose: Since the description of age-associated B cells (ABC), there has been a growing interest in the role of these cells in autoimmunity. Evidence suggests…
  • Abstract Number: 0470 • ACR Convergence 2021

    Inhibition of Toll-Like Receptor 7 (TLR7) with the Potent and Selective Inhibitor of Human TLR7 and TLR8 BMS-986256 Provides Robust Efficacy in Murine Lupus Models, Reversing Established Disease

    Shailesh Dudhgaonkar1, Anjuman Rudra1, Sourabh Ranade1, Siva Subramani1, Jignesh Nagar1, Preethi Karunanithi1, Priyadeep Bhutani1, Vishwanath Kurawattimath1, Rosemary Zhang2, Hongchen Qiu2, ALARIC DYCKMAN2 and Gary Schieven2, 1Biocon Bristol Myers Squibb Research Center, Bangalore, India, 2Bristol Myers Squibb, Lawrenceville, NJ

    Background/Purpose: TLR7, a member of the Toll-Like Receptor family, recognizes ssRNA and is primarily expressed in plasmacytoid dendritic cells and B cells. TLR7 has been…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology